Transoral vertebral augmentation with polymethylmethacrylate in the treatment of a patient with a dens fracture nonunion and subarticular vertebral body fracture of C2
โ Scribed by Douglas P. Beall; Matthew Stanfield; Hal D. Martin; Annette M. Stapp
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 262 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0364-2348
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Objective To determine the effect of 6 years of routine management on body composition, physical functioning, and quality of life, and their interrelationships, in men with idiopathic vertebral fracture. ## Methods Twenty men with idiopathic vertebral fracture (patients: mean ยฑ SD
## Abstract In the Fracture Intervention Trial (FIT) Long Term Extension (FLEX) Trial, 10 years of alendronate (ALN) did not significantly reduce the risk of nonvertebral fractures (NVFs) compared with 5 years of ALN. Continuing ALN reduced the risk of clinical but not morphometric vertebral fractu